With market volatility on the rise, put premiums are highly elevated, so it’s a good time to check in on Barchart’s Naked Put ...

Nearly $600M in deep out-of-the-money puts highlights tail-risk positioning, though flows point more to volatility strategies ...

Amphastar Pharmaceuticals is rated a Buy, with ~81% upside to a $33 fair value, despite margin pressures for 2026. AMPH faces declining sales in legacy products but expects mid- to high-single-digit ...

A snapshot of the top strategies to make money from a highly volatile market Heading into the new year, traders expecting more volatile markets may want to refresh their approach. Discover the top ...

A large institutional options fund may have contributed to some of the recent volatility in the S&P 500.